Your search returned 82 studies. (Get alerts for new studies):
- Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
Conditions: Systemic Sclerosis - Scleroderma - Pulmonary Hypertension - Pulmonary Arterial Hypertension
23 Locations available
- Rituximab for Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)
Conditions: Systemic Sclerosis-Associated Pulmonary Arterial Hypertension
12 Locations available
- Ranolazine and Pulmonary Hypertension
Conditions: Angina - Right Ventricular Ischemia - Pulmonary Arterial Hypertension
1 Location available
- Noninvasive Cardiac Output Measurements in Patients With Pulmonary Hypertension Undergoing Exercise Testing
Conditions: Pulmonary Hypertension
1 Location available
- Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
Conditions: Pulmonary Arterial Hypertension
53 Locations available
- Inhaled Prostaglandin E1 (IPGE1) for Hypoxemic Respiratory Failure (NHRF)
Conditions: Prematurity - Respiratory Insufficiency - Pulmonary Hypertension - Respiratory Distress Syndrome, Newborn
4 Locations available
- Side Effects of Pulmonary Hypertension Medications
Conditions: Pulmonary Hypertension
1 Location available
- Genetic and Environmental Characteristics of Primary Pulmonary Hypertension
Conditions: Lung Diseases - Hypertension, Pulmonary
1 Location available
- Pilot Study of the Safety and Efficacy of Carvedilol in Pulmonary Arterial Hypertension
Conditions: Pulmonary Arterial Hypertension
1 Location available
- Glutamine Therapy for Hemolysis-Associated Pulmonary Hypertension
Conditions: Pulmonary Hypertension - Sickle Cell Disease - Thalassemia
1 Location available
- Pharmacokinetic Study of Milrinone in Babies With Persistent Pulmonary Hypertension of the Newborn
Conditions: Persistent Pulmonary Hypertension of Newborn (PPHN)
3 Locations available
- ACT-293987 in Pulmonary Arterial Hypertension
Conditions: Pulmonary Arterial Hypertension
36 Locations available
- A Study of First-Line Ambrisentan and Tadalafil Combination Therapy in Subjects With Pulmonary Arterial Hypertension (PAH)
Conditions: Hypertension, Pulmonary
45 Locations available
- Ambrisentan in Patients With Porto-pulmonary Hypertension A Multicenter Open Label Trial
Conditions: Portopulmonary Hypertension
3 Locations available
- The Qutenza Patch as Treatment for Disabling Treprostinil (Remodulin) Infusion Site Pain
Conditions: Pulmonary Hypertension - Pulmonary Arterial Hypertension
1 Location available
- A 48-week Study of the Effect of Dual Therapy (Inhaled Treprostinil and Tadafafil) Versus Mono-therapy (Tadalafil), 2 FDA Approved Pulmonary Hypertens
Conditions: Hypertension, Pulmonary
1 Location available
- Reduced Contractile Reserve: a Therapeutic Target in Heart Failure With Preserved Ejection Fraction(HFpEF)
Conditions: Heart Failure With Preserved Ejection Fraction - Pulmonary Disease - Left Ventricular Hypertrophy/Hypertension
1 Location available
- Study of Sildenafil to Treat Newborns With Persistent Pulmonary Hypertension
Conditions: Persistent Pulmonary Hypertension - Respiratory Failure
7 Locations available
- Registry of Sarcoidosis Associated Pulmonary Hypertension (RESAPH)
Conditions: Sarcoidosis - Pulmonary Hypertension
1 Location available
- The Safety Evaluation of Aminophylline and Ambrisentan When Administered Orally Alone and in Combination to Healthy Volunteers
Conditions: High Altitude Pulmonary Hypertension
1 Location available
- PTGS1 Genetic Variation and Increased Risk for Persistent Pulmonary Hypertension of the Newborn
Conditions: Persistent Pulmonary Hypertension
1 Location available
- Ambrisentan (Letairis) for Sarcoidosis Associated Pulmonary Hypertension
Conditions: Sarcoidosis - Pulmonary Hypertension
1 Location available
- Anticoagulation For Pulmonary Hypertension in Sickle Cell Disease
Conditions: Pulmonary Hypertension
1 Location available
- Tezosentan in Pulmonary Arterial Hypertension
Conditions: Pulmonary Arterial Hypertension
2 Locations available
- Esmolol or Nitroglycerin Infusion for Blood Pressure Control Prior to Cardiopulmonary Bypass (CPB) in Cardiac Surgery
Conditions: Hypertension
1 Location available
- Iloprost for the Treatment of Pulmonary Hypertension in Adults With Congenital Heart Disease
Conditions: Pulmonary Arterial Hypertension - Congenital Heart Disease - Eisenmenger's Syndrome
1 Location available
- Efficacy and Safety of Ambrisentan in Children 8-18yrs
Conditions: Hypertension, Pulmonary
3 Locations available
- Addition of UT-15C SR to Pulmonary Arterial Hypertension Patients Currently Receiving Tyvaso®
Conditions: Pulmonary Arterial Hypertension
4 Locations available
- Impact of Inhaled Treprostinil Sodium on Ventilation Perfusion Matching
Conditions: Pulmonary Arterial Hypertension - Chronic Obstructive Pulmonary Disease
1 Location available
- Inhaled Nitric Oxide/INOpulse DS for Pulmonary Arterial Hypertension (PAH)
Conditions: Pulmonary Arterial Hypertension - Pulmonary Hypertension
4 Locations available
- An Extension Study for Patients Who Participated in the CAMN107X2201 Study
Conditions: Pulmonary Arterial Hypertension
2 Locations available
- Secondary Pulmonary Hypertension in Adults With Sickle Cell Anemia
Conditions: Pulmonary Hypertension - Sickle Cell Anemia
1 Location available
- A Dose Response Study of UT-15C SR in Patients With Exercise-Induced Pulmonary Hypertension
Conditions: Pulmonary Hypertension
1 Location available
- Transition From Injectable Prostacyclin Medication to Inhaled Prostacyclin Medication
Conditions: Pulmonary Arterial Hypertension
1 Location available
- Real-time MRI Right Heart Catheterization Using Passive Catheters
Conditions: Caridovascular Disease - Congenital Heart Disease - Pulmonary Hypertension
1 Location available
- Tadalafil for Sarcoidosis Associated Pulmonary Hypertension
Conditions: Pulmonary Hypertension
1 Location available
- Persistent Pulmonary Hypertension of the Newborn
Conditions: Persistent Fetal Circulation Syndrome
3 Locations available
- Integrated Diagnostics Characterization of Right Ventricular Diastolic Flow Dynamics in Pulmonary Arterial Hypertension
Conditions: Pulmonary Hypertension
1 Location available
- Investigation of Dysynchrony in Patients With Pulmonary Hypertension
Conditions: Pulmonary Hypertension
1 Location available
- Pharmacogenomics in Pulmonary Arterial Hypertension
Conditions: Pulmonary Arterial Hypertension - Pulmonary Hypertension - PAH WHO Group I
1 Location available
- Lung Protective Ventilation in Pulmonary Thromboendarterectomy (PTE) Patients
Conditions: Chronic Thromboembolic Pulmonary Hypertension - Acute Lung Injury
1 Location available
- The Expression and Significance of MiRNA
Conditions: Pulmonary Arterial Hypertension
1 Location available
- Insulin Resistance in Pulmonary Arterial Hypertension
Conditions: Hypertension, Pulmonary
1 Location available
- Safety and Efficacy Trial to Treat Diastolic Heart Failure Using Ambrisentan
Conditions: Pulmonary Hypertension - Heart Failure With Preserved Ejection Fraction
1 Location available
- Ventavis® Registry Protocol
Conditions: Pulmonary Arterial Hypertension
31 Locations available
- Safety and Efficacy of Fluoxetine in Pulmonary Arterial Hypertension
Conditions: Pulmonary Arterial Hypertension
1 Location available
- Phase 2 Study of Ex-vivo Perfusion and Ventilation of Lungs to Assess Transplant Suitability
Conditions: Emphysema - Chronic Obstructive Pulmonary Disease (COPD) - Cystic Fibrosis - Pulmonary Fibrosis - Bronchiectasis - Sarcoidosis - Pulmonary Hypertension - Alpha-1 Antitrypsin Deficiency
2 Locations available
- Hyperpolarized 129Xe MRI for Imaging Pulmonary Function
Conditions: Asthma - Chronic Obstructive Pulmonary Disease - Interstitial Lung Disease - Cystic Fibrosis - Pulmonary Hypertension
1 Location available
- An Open-Label Uncontrolled Study of the Safety and Efficacy of Ambrisentan in Patients With Exercise Induced Pulmonary Arterial Hypertension and Diast
Conditions: Exercised Induced Pulmonary Arterial Hypertension - Diastolic Dysfunction
1 Location available
- Long-term Ambrisentan Extension Study for Pediatric Patients Who Participated in AMB112529
Conditions: Hypertension, Pulmonary
2 Locations available
- Safety, Tolerability, and PK Parameters of Sodium Nitrite Inhalation Solution in Healthy Subjects
Conditions: Pulmonary Hypertension - Pulmonary Arterial Hypertension
1 Location available
- Study the Effects of Spironolactone on Collagen Metabolism in Patients With Pulmonary Arterial Hypertension
Conditions: Pulmonary Hypertension
1 Location available
- Assessmet of Patients With PAH Right Ventricular Volume
Conditions: Pulmonary Arterial Hypertension
2 Locations available
- Predictors of Pulmonary Hypertension Risk in Premature Infants With Bronchopulmonary Dysplasia
Conditions: Bronchopulmonary Dysplasia (BPD) - Pulmonary Hypertension (PH)
1 Location available
- Effects of the Combination of Bosentan and Sildenafil Versus Sildenafil Monotherapy on Pulmonary Arterial Hypertension (PAH)
Conditions: Pulmonary Hypertension
41 Locations available
- Aerobic Exercise in Patients With Pulmonary Hypertension
Conditions: Hypertension, Pulmonary
3 Locations available
- A Clinical Trial of Ambrisentan and Tadalafil in Pulmonary Arterial Hypertension Associated With Systemic Sclerosis
Conditions: Pulmonary Arterial Hypertension - Systemic Sclerosis - Scleroderma Spectrum of Diseases - Connective Tissue Disease - Pulmonary Hypertension
1 Location available
- Exercise Induced Pulmonary Hypertension in Systemic Sclerosis and Treatment With Ambrisentan
Conditions: Systemic Sclerosis - Shortness of Breath - Pulmonary Hypertension
1 Location available
- Sedation With Dexmedetomidine During Cardiac Catheterization
Conditions: Pulmonary Hypertension
1 Location available
- Clevidipine for Vasoreactivity Evaluation of the Pulmonary Arterial Bed
Conditions: Hypertension, Pulmonary
1 Location available
- Pulmonary Arterial Hypertension in Children
Conditions: Pulmonary Arterial Hypertension
5 Locations available
- Biomarkers in Pulmonary Arterial Hypertension Treated With Nilotinib
Conditions: PAH
1 Location available
- Study of Exercise and Heart Function in Patients With Heart Failure and Pulmonary Vascular Disease
Conditions: Exercise Tolerance - Dyspnea - Heart Failure - Pulmonary Hypertension
1 Location available
- Vascular Subphenotypes of Lung Disease in HIV & COPD
Conditions: Pulmonary Artery Hypertension
1 Location available
- Remodulin® to Oral Treprostinil Transition
Conditions: Pulmonary Arterial Hypertension
2 Locations available
- Chronic Sildenafil for Severe Diaphragmatic Hernia
Conditions: Hernia, Diaphragmatic - Hypertension, Pulmonary - Hypoplasia, Pulmonary
2 Locations available
- Inhaled Iloprost as an Adjunct to Inhaled Nitric Oxide in Pediatric Critical Care Patients
Conditions: Pulmonary Hypertension - Neonatal Hypoxic Respiratory Failure - Persistent Pulmonary Hypertension of Newborn - Congenital Heart Defects - Acute Respiratory Distress Syndrome
1 Location available
- Tezosentan in Patients With Pulmonary Arterial Hypertension
Conditions: Pulmonary Arterial Hypertension
1 Location available
- Coenzyme Q-10 and Pulmonary Arterial Hypertension
Conditions: Pulmonary Arterial Hypertension
1 Location available
- Efficacy, Safety, Tolerability and Pharmacokinetics (PK) of Nilotinib (AMN107) in Pulmonary Arterial Hypertension (PAH)
Conditions: Pulmonary Arterial Hypertension
2 Locations available
- Study of Incidence of Respiratory Tract Adverse Events in Patients Treated With Tyvaso® Compared to Other FDA Approved Pulmonary Arterial Hypertension
Conditions: Pulmonary Arterial Hypertension
59 Locations available
- Effects of Ventavis in Patients With Pulmonary Hypertension (PH) Secondary to Chronic Obstructive Pulmonary Disease (COPD)
Conditions: Pulmonary Hypertension - Chronic Obstructive Pulmonary Disease
6 Locations available
- Oral Iron Supplementation in Pulmonary Hypertension
Conditions: Pulmonary Arterial Hypertension
1 Location available
- Early Detection of Pulmonary Arterial Hypertension Using Cardiac Magnetic Resonance Imaging
Conditions: Pulmonary Hypertension - Pulmonary Arterial Hypertension
1 Location available
- Safety Study of Gleevec® in Children With Pulmonary Hypertension
Conditions: Pulmonary Hypertension
1 Location available
- A Study to Assess the Safety and Efficacy of Treprostinil to Facilitate Liver Transplantation in Patients With Portopulmonary Hypertension
Conditions: Portopulmonary Hypertension - Pulmonary Arterial Hypertension - Pulmonary Hypertension
2 Locations available
- Extension to QTI571A2301 to Evaluate the Long-term Safety, Tolerability and Efficacy of Imatinib in Severe Pulmonary Arterial Hypertension
Conditions: Pulmonary Arterial Hypertension
10 Locations available
- Study in Subjects With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension (PH) Secondary to Idiopathic Pulmonary Fibrosis (IPF) Using In
Conditions: Pulmonary Arterial Hypertension (PAH) - Pulmonary Hypertension-Idiopathic Pulmonary Fibrosis (PH-IPF)
10 Locations available
- Noninvasive Cardiac Output Measurements in Patients With Pulmonary Hypertension Undergoing Right Heart Catheterization With Acute Vasodilator Testing
Conditions: Pulmonary Hypertension
1 Location available
- Pilot Study of the Safety and Efficacy of Anakinra (Recombinant Human Interleukin-1 Receptor Antagonist) in Pulmonary Hypertension
Conditions: Pulmonary Hypertension
1 Location available
- Combined Use of Angiography, Optical Coherence Tomography and Intravascular Ultrasound in Evaluation of Pulmonary Vascular Structure and Function in P
Conditions: Pulmonary Arterial Hypertension
1 Location available
- Imatinib and Carvedilol for High Blood Pressure in the Lungs in Adults With Sickle Cell Disease
Conditions: Pulmonary Hypertension Inclusion Criteria 1. Must be Unaffected by a Neurologica
1 Location available
|